Literature DB >> 3106507

Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa.

B M Greenwood, A M Greenwood, A K Bradley, K Williams, M Hassan-King, F C Shenton, R A Wall, R J Hayes.   

Abstract

A study was made of factors that influenced susceptibility to group A meningococcal disease during an epidemic that affected The Gambia, West Africa during the dry season of 1982-83. No explanations were found for the distribution of cases between villages or within affected villages. Socio-economic status, crowding, nutrition and previous exposure to meningococcal disease all appeared to be unimportant. Examination of serum samples obtained before the outbreak from a few children who subsequently became patients and from an equal number of age-matched controls from the same village showed a higher mean serum IgA value in children who became patients than in controls. There were not, however, any significant differences found in the concentrations of IgG, IgM, complement or meningococcal antibody between the two groups. Four children who developed culture-proven group A meningococcal disease had raised titres of bactericidal antibody to the epidemic strain 2-3 months before their illnesses. Our findings suggest that some important risk factors for group A meningococcal disease remain to be identified.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106507     DOI: 10.1016/s0163-4453(87)92052-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  14 in total

Review 1.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

2.  Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles.

Authors:  N Bharti; H Broutin; R F Grais; M J Ferrari; A Djibo; A J Tatem; B T Grenfell
Journal:  Epidemiol Infect       Date:  2011-10-05       Impact factor: 2.451

3.  Carriage of Neisseria meningitidis: investigations in a military establishment.

Authors:  J V Pether; N F Lightfoot; R J Scott; J Morgan; A P Steele-Perkins; S C Sheard
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

4.  Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia.

Authors:  Natalia Ilyina; Susanna Kharit; Leila Namazova-Baranova; Asmik Asatryan; Mayya Benashvili; Elmira Tkhostova; Chiranjiwi Bhusal; Ashwani Kumar Arora
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Tsegaye Alebel; Degu Berhanu; Morten Harboe; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Knowledge, attitudes, and practices related to meningitis in northern Ghana.

Authors:  Mary H Hayden; Maxwell Dalaba; Timothy Awine; Patricia Akweongo; Gertrude Nyaaba; Dominic Anaseba; Jamie Pelzman; Abraham Hodgson; Rajul Pandya
Journal:  Am J Trop Med Hyg       Date:  2013-06-17       Impact factor: 2.345

7.  Smoking, the environment and meningococcal disease: a case control study.

Authors:  R E Stanwell-Smith; J M Stuart; A O Hughes; P Robinson; M B Griffin; K Cartwright
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

8.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

9.  Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.

Authors:  M Achtman; M Neibert; B A Crowe; W Strittmatter; B Kusecek; E Weyse; M J Walsh; B Slawig; G Morelli; A Moll
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Serogroup W135 meningococcal disease, The Gambia, 2012.

Authors:  M Jahangir Hossain; Anna Roca; Grant A Mackenzie; Momodou Jasseh; Mohammad Ilias Hossain; Shah Muhammad; Manjang Ahmed; Osuorah Donatus Chidiebere; Ndiaye Malick; S M Bilquees; Usman N Ikumapayi; Baba Jeng; Baba Njie; Mamady Cham; Beate Kampmann; Tumani Corrah; Stephen Howie; Umberto D'Alessandro
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.